Department of Epidemiology, Local Health Unit Roma E, Roma, Italy.
Drug Alcohol Rev. 2010 May;29(3):304-17. doi: 10.1111/j.1465-3362.2009.00132.x.
Cross-sectional surveys have revealed that cannabis is the most widely used illicit substance in Western countries. Cannabis intoxication can lead to acute, transient psychotic symptoms and the short-term exacerbation of pre-existing psychotic symptoms. However, controversy exists about whether cannabis can actually cause long-term psychosis.
We summarised the findings of systematic reviews on the association between cannabis use and psychosis, searching MEDLINE, EMBASE and CINAHL up to August 2007. We assessed the methodological quality, selected the better quality reviews and analysed reasons for discordant results.
We included five systematic reviews. Four of the reviews performed a meta-analysis and showed a consistent association between cannabis use and psychosis; the fifth review considered psychological problems more broadly, did not perform a meta-analysis and reported an inconsistent association. The reasons for discordance were: different outcomes (psychosis vs. psychological problems), different inclusion criteria for primary studies and different methods for summarising the results.
This overview shows a consistent association between cannabis use and psychotic symptoms, though it is not possible to draw firm conclusions about a causal relationship. Reverse causality and residual confounding cannot be excluded. An interaction with other environmental and genetic factors is difficult to ascertain.
We conclude that there is insufficient knowledge to determine the level of risk associated with cannabis use in relation to psychotic symptoms and that more information is needed on both the risks of cannabis use and the benefits of preventive interventions to support evidence-based approaches in this area.
横断面调查显示,大麻是西方国家最广泛使用的非法物质。大麻中毒可导致急性、短暂的精神病性症状和先前存在的精神病性症状的短期恶化。然而,大麻是否真的会导致长期精神病仍存在争议。
我们总结了关于大麻使用与精神病之间关联的系统评价研究结果,检索了 MEDLINE、EMBASE 和 CINAHL,截至 2007 年 8 月。我们评估了方法学质量,选择了质量较好的综述,并分析了结果不一致的原因。
我们纳入了五项系统评价。其中四项综述进行了荟萃分析,表明大麻使用与精神病之间存在一致关联;第五项综述更广泛地考虑了心理问题,未进行荟萃分析,报告了不一致的关联。不一致的原因是:不同的结局(精神病与心理问题)、主要研究的不同纳入标准和不同的结果总结方法。
该综述表明大麻使用与精神病症状之间存在一致关联,但不能确定因果关系。不能排除反向因果关系和残留混杂因素。与其他环境和遗传因素的相互作用也难以确定。
我们的结论是,关于大麻使用与精神病症状相关的风险水平,目前还没有足够的知识来确定,需要更多关于大麻使用风险和预防干预措施效益的信息,以支持该领域的循证方法。